• Home
  • About
  • Investors
  • Science
  • Announcements
cardiogeni.com

Cardiogeni PLC – Annual Results to 31 March 2025

by ollie@ojtdigital.com | Sep 30, 2025 | Uncategorized

Cardiogeni PLC – Annual Results to 31 March 2025 RNS Number : 4956B Cardiogeni PLC 30 September 2025 30 September 2025 Cardiogeni plc (“Cardiogeni” or the “Company”) Annual Results to 31 March 2025 Cardiogeni PLC  (AQSE:...

Cardiogeni PLC – Board Appointment of (Lord) James Nicholas Bethell

by ollie@ojtdigital.com | Aug 29, 2025 | Uncategorized

Cardiogeni PLC – Board Appointment of (Lord) James Nicholas Bethell RNS Number : 2504X Cardiogeni PLC 29 August 2025 The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse...

Cardiogeni PLC – Details of Advanced Subscription & Company Update

by ollie@ojtdigital.com | Jul 24, 2025 | Uncategorized

Cardiogeni PLC – Details of Advanced Subscription & Company Update RNS Number : 4945S Cardiogeni PLC 24 July 2025 This announcement contains information which, prior to its disclosure, was inside information as stipulated under Regulation 11 of the Market...

Cardiogeni PLC – £150,000 Advanced Subscription Agreement

by ollie@ojtdigital.com | Jul 24, 2025 | Uncategorized

Cardiogeni PLC – £150,000 Advanced Subscription Agreement RNS Number : 2915S Cardiogeni PLC 24 July 2025 This announcement contains information which, prior to its disclosure, was inside information as stipulated under Regulation 11 of the Market Abuse...

Cardiogeni PLC – Appointment of corporate broker

by ollie@ojtdigital.com | Jul 2, 2025 | Uncategorized

Cardiogeni PLC – Appointment of corporate broker RNS Number : 2844P Cardiogeni PLC 02 July 2025 2 July 2025 Cardiogeni PLC (“Cardiogeni” or the “Company”) Appointment of Corporate Broker Cardiogeni (AQSE: CGNI), the UK clinical...

Cardiogeni PLC – TR-1: Notification of major holdings

by ollie@ojtdigital.com | Jun 3, 2025 | Uncategorized

Cardiogeni PLC – TR-1: Notification of major holdings RNS Number : 2759L Cardiogeni PLC 03 June 2025 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:Cardiogeni PLC1b. Please indicate if the...
« Older Entries
Next Entries »
Cardiogeni is committed to advancing pioneering cellular therapies that repair and reactivate heart tissue leading to improved heart health. Guided by world-leading science, commercial excellence and a dedication to patient impact, we strive to deliver safe, effective, and life-changing solutions for those living with heart failure.

Navigation

  • Home
  • About
  • Investors
  • Science
  • Announcements

Socials

  • Follow

Address

Cardiogeni Plc
Celixir House,
Innovation Way,
Stratford-Upon-Avon,
England,
CV37 7GZ

© 2025 Cardiogeni. All rights reserved.

Terms and Conditions | Privacy Policy

Designed By: